Passionate about returning Big Pharma's power to the people, Marc DeValera, founder of MLFD-MedTech Inc., developed 3 ...

Japan: A recent study published in Annals of Allergy, Asthma & Immunology has highlighted the potential of the baseline ...

The Asthma Society of Ireland has warned that over-use of steroid medication may cause more harm than good. A study has shown ...

The increasing demand for asthma treatment is largely driven by the rising number of asthma cases. Factors such as increased smoking and air pollution are impairing lung function and contributing to ...

An asthma attack always requires prompt treatment to prevent life-threatening complications. Treatment varies from person to person but typically includes medications that reduce airway ...

Depemokimab has already shown its potential as a therapy for severe asthma in two other phase 3 trials – SWIFT-1 and SWIFT-2 ...

Asthma affects about seven million children in the U.S. But kids who have asthma can lead normal, active lives with the right ...

In another Gazzette notification, the drug pricing regulator fixed the retail price of 20 new drugs under the provisions of ...

India's drug pricing authority has increased the prices of essential drugs for conditions like asthma and tuberculosis, ...

The National Pharmaceutical Pricing Authority (NPPA) has sanctioned the ceiling price hike for 11 formulations by 50 per cent ...

The global asthma treatment market size was valued at USD 27.51 billion in 2023 and is expected to reach around USD 35.93 billion by 2034. It is growing at a CAGR of 2.42% from 2024 and 2034. The ...